Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2 /neu or EpCAM as target receptorsJan R.H. Hanauer, Michael D. Mühlebach, Dennis Riehl et al.|Molecular Therapy — Oncolytics|2016Cited by 22
Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and TemozolomideKatharina Otte, Tillmann Rusch|Biomedicines|2022Cited by 4
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1Kai Zhao, Tillmann Rusch|Cells|2024Cited by 4